Pancreatic Cancer Stage Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Pancreatic Cancer Stage clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Breast Cancer MetastaticHER2-Negative Breast CarcinomaPancreatic Cancer+17 more
General Oncology, Inc.24 enrolled2 locationsNCT04150042
Recruiting

Pancreatic Cancer Detection Consortium

Pancreatic CancerPancreatic CarcinomaPancreatic Ductal Adenocarcinoma+10 more
City of Hope Medical Center2,000 enrolled11 locationsNCT06388967
Recruiting
Phase 1Phase 2

Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

Pancreatic CancerPancreatic CarcinomaPancreatic Cancer Stage IV+1 more
Essen Biotech60 enrolled1 locationNCT07066995
Recruiting
Phase 2Phase 3

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Pancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IVPancreatic Cancer Metastatic
Panbela Therapeutics, Inc.600 enrolled93 locationsNCT05254171
Recruiting
Phase 3

A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer Stage IVPancreatic Cancer Metastatic
RenJi Hospital401 enrolled6 locationsNCT04674956
Recruiting

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Pancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IVPancreatic Neoplasms+1 more
Nuvance Health200 enrolled1 locationNCT04406831
Recruiting
Phase 3

Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

Pancreatic Cancer Stage IVChemotherapy Induced Nausea and Vomiting
Fudan University100 enrolled1 locationNCT06017284